Skip to content

Rhythmic Auditory Stimulation on Neural Activity During Finger-tapping in PD Patients

Effects and Neural Mechanisms of Rhythmic Auditory Stimulation on Upper-limb Movements in Patients With Parkinson's Disease

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05839821
Enrollment
72
Registered
2023-05-03
Start date
2023-06-01
Completion date
2026-03-31
Last updated
2023-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acoustic Stimulation, Electroencephalography, Parkinson Disease

Keywords

Acoustic Stimulation, Parkinson Disease, Movement, Electroencephalography

Brief summary

Introduction Bradykinesia (i.e., slow movements) is one of the most prominent symptoms of Parkinson's disease (PD) and has a negative impact on quality of life. Rhythmic auditory stimulation (RAS), a widely used and promising treatment technique, has been shown to effectively improve gait speed in PD patients. However, only few studies have explored effects and neural mechanisms of RAS on upper-limb movements. The investigators will conduct two studies to investigate effects and mechanisms of RAS on upper-limb movements in PD patients. The purpose of this study is to examine real-time neural activity when patients with PD and healthy controls listen to RAS and execute finger-tapping task simultaneously. Methods and analysis This study will recruit patients with PD and healthy controls. Electroencephalography (EEG) will be used under six conditions related to a finger-tapping task. Two-way repeated measures analysis of variance will be performed to investigate the group and condition effects on neural mechanisms. Study significance This study will offer evidence on RAS effects and mechanisms by investigating the changes in upper-limb movements and neural mechanisms during auditory-motor entrainment. Results from this study will provide a solid foundation for further research and clinical applications of RAS.

Interventions

BEHAVIORALnoF-noRAS

resting state, that is, without finger-tapping and without listening to RAS

BEHAVIORALF-noRAS

finger-tapping without listening to RAS

BEHAVIORALnoF-100RAS

listening to RAS with the 100% of the baseline tempo and without finger-tapping

BEHAVIORALF-100RAS

finger-tapping and listening to RAS with 100 % of baseline tempo

BEHAVIORALF-105RAS

finger-tapping and listening to RAS with 105 % of baseline tempo

BEHAVIORALF-110RAS

finger-tapping and listening to RAS with 110 % of baseline tempo

Sponsors

The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* (a) idiopathic PD diagnosed by a neurologist based on the Movement Disorders Society clinical diagnostic criteria; * (b) the Hoehn and Yahr stage is 2 or 3, meaning that bilateral movement problems or combination with mild postural instability; * (c) a score of Montreal Cognitive Assessment (MoCA) is equal to or higher than 21 to ensure that they understand experimental instructions; * (d) a score of Edinburgh Handedness Inventory is above 60 to ensure that they are right-handed; * (e) types and doses of medications remain unchanged in the past month right before participation. * Age- and sex-matched healthy controls who filled the criteria (c) and (d) will be recruited from communities.

Exclusion criteria

* the presence of medical conditions or diseases that may affect hand movements, vision, or hearing based on self-report.

Design outcomes

Primary

MeasureTime frameDescription
The spectral power analysis of Electroencephalography (EEG)EEG will be continuously recorded during the whole experiment, which is about 20 minutes.The spectral power analysis (unit: watt) will be conducted
The functional connectivity analysis of Electroencephalography (EEG)EEG will be continuously recorded during the whole experiment, which is about 20 minutes.The functional connectivity analysis (unit: coherence) will be conducted

Contacts

Primary ContactWei FAN (PhD student), MSc
21037721r@connect.polyu.hk+85267681229
Backup ContactShu-mei Wang (supervisor), PhD
shumei.wang@polyu.edu.hk+85227664197

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026